Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062940
Filing Date
2023-11-13
Accepted
2023-11-13 16:10:27
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-20230930.htm   iXBRL 10-Q 2486209
2 EX-4.1 elox-ex4_1.htm EX-4.1 147629
3 EX-4.2 elox-ex4_2.htm EX-4.2 158131
4 EX-4.3 elox-ex4_3.htm EX-4.3 168179
5 EX-10.1 elox-ex10_1.htm EX-10.1 421062
6 EX-10.2 elox-ex10_2.htm EX-10.2 110247
7 EX-10.3 elox-ex10_3.htm EX-10.3 127529
8 EX-10.4 elox-ex10_4.htm EX-10.4 72572
9 EX-10.5 elox-ex10_5.htm EX-10.5 73787
10 EX-31.1 elox-ex31_1.htm EX-31.1 15285
11 EX-31.2 elox-ex31_2.htm EX-31.2 16307
12 EX-32.1 elox-ex32_1.htm EX-32.1 7788
13 EX-32.2 elox-ex32_2.htm EX-32.2 7929
  Complete submission text file 0000950170-23-062940.txt   9237927

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elox-20230930_def.xml EX-101.DEF 156010
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elox-20230930_pre.xml EX-101.PRE 311632
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elox-20230930_cal.xml EX-101.CAL 51841
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elox-20230930_lab.xml EX-101.LAB 411396
18 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elox-20230930.xsd EX-101.SCH 55107
64 EXTRACTED XBRL INSTANCE DOCUMENT elox-20230930_htm.xml XML 1370719
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 231398781
SIC: 2836 Biological Products, (No Diagnostic Substances)